WNK2 and familial atrioventricular septal defect: In recent years, remarkable advances have been made in the understanding of the pathogenesis of ECD with the discovery of recurrent BRAFV600E and other activating mitogen-activated protein kinase (MAPK) pathway mutations in ECD tissue [5–8].